Logo-bi
Original Research

1. Effect of Turmeric and Carrot Seed Extracts on Serum Liver Biomarkers and Hepatic Lipid Peroxidation, Antioxidant Enzymes and Total Antioxidant Status in Rats
Adel Rezaei-Moghadam, Daryoush Mohajeri, Behnam Rafiei, Rana Dizaji, Asghar Azhdari, Mahdi Yeganehzad, Maryamossadat Shahidi, Mohammad Mazani*
Bioimpacts. 2012;2(3): 151-157. doi: 10.5681/bi.2012.020
PMCID: PMC3648928     PMID: 23678453     Scopus ID: 84876731451    
Article
PDF
XML
Cited By:
20
10
0
Original Research

2. Investigation of the binding mechanism and inhibition of bovine liver catalase by quercetin: Multi-spectroscopic and computational study
Samaneh Rashtbari, Gholamreza Dehghan*, Reza Yekta, Abolghasem Jouyban
Bioimpacts. 2017;7(3): 147-153. doi: 10.15171/bi.2017.18
PMCID: PMC5684506     PMID: 29159142     Scopus ID: 85032025147    
Article
PDF
Full Text
XML
Cited By:
38
8
36
Original Article

3. PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy
Mina Yousefnezhad, Soodabeh Davaran* ORCID, Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi
Bioimpacts. 2023;13(3): 241-253. doi: 10.34172/bi.2023.24252
PMCID: PMC10329752     PMID: 37431480     Scopus ID: 85157052599    
Article
PDF
Full Text
XML
Cited By:
10
0
4
Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).
Original Article

4. Systemic nitric oxide metabolites and the chance of pre-diabetes regression to normoglycemia: A 9-year cohort study

Zahra Bahadoran ORCID, Parvin Mirmiran, Fereidoun Azizi, Asghar Ghasemi* ORCID
Bioimpacts. 2024;14(5): 29917. doi: 10.34172/bi.2024.29917
PMCID: PMC11406430     PMID: 39296799     Scopus ID: 85209255799    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
0
Review

5. Material synthesis and design optimization of biomaterials for biomedical implant applications
Nilesh Tipan* ORCID, Ajay Pandey, Pushyamitra Mishra
Bioimpacts. 2025;15: 30010 | Published on: 2024 Jun 29. doi: 10.34172/bi.30010
Article
PDF
XML
Cited By:
0
0
0
Review

6. STAT signaling pathways in immune cells and their associated mechanisms in cancer pathogenesis
Sepideh Sohrabi ORCID, Shiva Alipour ORCID, Zahra Ghahramanipour ORCID, Javad Masoumi, Behzad Baradaran* ORCID
Bioimpacts. 2025;15: 30030 | Published on: 2024 May 11. doi: 10.34172/bi.30030
Article
PDF
Full Text
XML
Cited By:
0
0
2
Original Article Special issue | AI & Bioinformatics

7. Evaluation of specific lncRNAs, miRNAs, and mRNAs in different groups of prostate cancer
Gelareh Vahabzadeh ORCID, Amirreza Pashapour-Yeganeh, Maryam Eini, Morad Roudbaraki, Ebrahim Esmati, Amirhoushang Poorkhani, Solmaz Khalighfard, Ali Mohammad Alizadeh* ORCID
Bioimpacts. 2025;15: 30510 | Published on: 2025 Jan 26. doi: 10.34172/bi.30510
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By:
0
0
0
Original Article

8. Chrysosplenetin B suppresses the growth of human prostate cancer cells by inducing G1 cell cycle arrest
Gang He* ORCID, Yanjiao Feng, Tangcong Chen, Yiyuan Zhang, Li Liang, Jun Yan, Yanxia Song, Fengzheng Chen, Wei Liu* ORCID
Bioimpacts. 2025;15: 30688 | Published on: 2025 Mar 02. doi: 10.34172/bi.30688
Article
PDF
Suppl 1
XML
Cited By:
0
0
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons